Agile Therapeutics Share Holder Equity 2013-2023 | AGRX
Agile Therapeutics share holder equity from 2013 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
Agile Therapeutics Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$-16 |
| 2022 |
$-6 |
| 2021 |
$4 |
| 2020 |
$49 |
| 2019 |
$46 |
| 2018 |
$20 |
| 2017 |
$36 |
| 2016 |
$42 |
| 2015 |
$30 |
| 2014 |
$36 |
| 2013 |
$-71 |
| 2012 |
$-59 |
Agile Therapeutics Quarterly Share Holder Equity
(Millions of US $) |
| 2023-12-31 |
$-16 |
| 2023-09-30 |
$-12 |
| 2023-06-30 |
$-12 |
| 2023-03-31 |
$-9 |
| 2022-12-31 |
$-6 |
| 2022-09-30 |
$6 |
| 2022-06-30 |
$3 |
| 2022-03-31 |
$3 |
| 2021-12-31 |
$4 |
| 2021-09-30 |
$11 |
| 2021-06-30 |
$25 |
| 2021-03-31 |
$35 |
| 2020-12-31 |
$49 |
| 2020-09-30 |
$66 |
| 2020-06-30 |
$81 |
| 2020-03-31 |
$91 |
| 2019-12-31 |
$46 |
| 2019-09-30 |
$32 |
| 2019-06-30 |
$23 |
| 2019-03-31 |
$25 |
| 2018-12-31 |
$20 |
| 2018-09-30 |
$23 |
| 2018-06-30 |
$26 |
| 2018-03-31 |
$31 |
| 2017-12-31 |
$36 |
| 2017-09-30 |
$42 |
| 2017-06-30 |
$29 |
| 2017-03-31 |
$36 |
| 2016-12-31 |
$42 |
| 2016-09-30 |
$47 |
| 2016-06-30 |
$54 |
| 2016-03-31 |
$61 |
| 2015-12-31 |
$30 |
| 2015-09-30 |
$33 |
| 2015-06-30 |
$41 |
| 2015-03-31 |
$49 |
| 2014-12-31 |
$36 |
| 2014-09-30 |
$42 |
| 2014-06-30 |
$48 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
|
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2012-12-31 |
$-59 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.003B |
$0.020B |
|
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
|
